Donaghue Women's Health Investigator Program awards grants to three at Yale

June 30, 2004

New Haven, Conn. - The Ethel F. Donaghue Women's Health Investigator Program, administered by Women's Health Research at Yale, has granted its 2004 Program Awards to three Yale researchers. The program offers grants to full-time Yale affiliated investigators for new research on women's health and on the sex-specific factors in health and disease.

The awardees include Ronald S. Duman, professor of psychiatry and pharmacology and director of the Abraham Ribicoff Research Facilities; Deborah D. Proctor, M.D., associate professor of medicine in the Department of Internal Medicine; and Christopher H. van Dyck, M.D., associate professor of psychiatry (geropsychiatry) and neurobiology.

"Again this year, the quality of the submissions we evaluated speaks to the significant work going on at Yale, and to the desire on the part of researchers to factor gender into their investigations in order to improve outcomes," said Carolyn M. Mazure, director of Women's Health Research at Yale. "Our program's research agenda is designed to generate information that is useful to women and healthcare providers, and to serve as a model for wider application of innovative interdisciplinary research."

Duman's study will explore the neurobiological mechanisms that underlie postpartum depression (PPD), which poses a highly significant health risk for women as well as their children. Although there is evidence suggesting that the dramatic fluctuation in hormone levels experienced shortly after birth can contribute to PPD, the neurobiology that underlies this disorder has not been identified. Duman will address this issue by conducting a series of integrated studies in an animal model of PPD. The findings of these studies will be used for expanding research approaches to PPD and for developing novel treatment strategies.

Proctor will generate pilot data on 20 women with hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome, who have severe, chronic gastrointestinal bleeding. The results will indicate the feasibility of a larger trial determining the optimal therapy to control the bleeding in these patients - systemic estrogen-progesterone therapy or endoscopic cautery. Currently, there is little data to guide physicians in treating these women.

van Dyck's research focuses on estrogen and serotonin receptors in menopausal women with depression. His study will examine the serotonin-2A receptor in the brain, especially in the prefrontal cortex. This receptor appears to be involved in the regulation of mood and the actions of antidepressants. Results from this work will enhance understanding of the neurobiology of peri- and postmenopausal depression and may have profound effects on the treatment of depression during this stage in women's lives.

The Ethel F. Donaghue Women's Health investigator Program at Yale was established with a grant from The Patrick & Catherine Weldon Donaghue Medical Research Foundation of West Hartford, CT. The foundation focuses on initiatives to strengthen research on health issues, to promote future research leadership, and to put new knowledge to work for public benefit.

The launch of The Ethel F. Donaghue Women's Health Investigator Program at Yale in 1998 generated an unprecedented opportunity to advance research on the health of women, and provided the groundwork for the formation of Women's Health Research at Yale - the largest, self-supporting interdisciplinary research program of its kind in the nation. The program continues to provide grants at Yale, supporting over 40 innovative research projects in diverse areas of biological and behavioral research. These studies examine the most pressing health concerns for women today, and explore sex differences in health and disease.

From the program's seed grants of $3.6 million awarded to date, the granted scientists have generated pilot data establishing the basis for further studies and findings that could be immediately applied. Based on data from these studies, program investigators have received over $15.5 million of new external research funding for their laboratories, including many research and training grants from the National Institutes of Health to study sex differences in an array of health areas.
Women's Health Research at Yale is committed to educational outreach and communicating the findings of new research to the public, as well as to scientific audiences and health care providers. More information is available on the program's web site at

Yale University

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to